Vaccination of C57BL/10 mice against cutaneous leishmaniasis using killed promastigotes of different strains and species of Leishmania.

Resumo
Antigenic extracts from five Leishmania stocks were used to vaccinate C57BL/10 mice. The Leishvacinand PH8 monovalent vaccine yielded the highest IFN-levels in the supernatants of spleen cell culture from vaccinated animals. Each single strain immunized group showed evidence of protective immunity six months after the challenge with promastigotes of Leishmania (Leishmania) amazonensis. No differences were detected between the vaccinated groups. It can be concluded that vaccines composed of single Leishmania stocks can provide protection to C57BL/10 mice against L. (L.) amazonensis infection.
Descrição
Palavras-chave
Vaccine, Interferon, Interleukin, Leishmania, Vacina
Citação
MAYRINK, W. Vaccination of C57BL/10 mice against cutaneous leishmaniasis using killed promastigotes of different strains and species of Leishmania. Revista do Instituto de Medicina Tropical de São Paulo, São Paulo, v. 35, n. 2, p. 125-132, 2002. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822002000200001&lng=en&nrm=iso&tlng=en>. Acesso em: 01 set. 2014.